🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy, such as doxorubicin hydrochloride, b...
Status
Terminated
Location
Stanford Cancer Center
Start Date
2013-05-24
Trial ID
NCT01390584
This study aims to evaluate the efficacy brentuximab vedotin as consolidati...
Status
Completed
Location
CH Victor Dupouy
Start Date
2015-04
Trial ID
NCT02298283
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Unknown
Location
Universitair Medisch Centrum St. Radboud - Nijmegen
Start Date
2006-10
Trial ID
NCT00433433
Treatments Being Tested
The standard chemotherapy for Hodgkin lymphoma is called ABVD which is a co...
Status
Completed
Location
City of Hope Comprehensive Cancer Center
Start Date
2012-04
Trial ID
NCT01578967
Treatments Being Tested
The purpose of this study is to test how safe and effective the research st...
Status
Unknown
Location
Concord Hospital
Start Date
2018-11-29
Trial ID
NCT03331731
Treatments Being Tested
Hodgkin Lymphoma patients with limited stage are commonly cured with limite...
Status
Recruiting
Location
Sahlgrenska University Hospital
Start Date
2019-09-01
Trial ID
NCT06883604
Treatments Being Tested
The purpose of this study is to assess the safety profile of brentuximab ve...
Status
Completed
Location
Mayo Clinic
Start Date
2010-01
Trial ID
NCT01060904
Treatments Being Tested
Combined modality therapy has then emerged as the standard of care for limi...
Status
Terminated
Location
UT MD Anderson Cancer Center
Start Date
2009-09
Trial ID
NCT00992030
Treatments Being Tested
Early interim-PET after two courses of chemotherapy is a powerful outcome p...
Status
Unknown
Location
Azienda Ospedaliera Santa Croce e Carle
Start Date
2006-01
Trial ID
NCT00877747
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Status
Completed
Location
City of Hope Comprehensive Cancer Center
Start Date
2006-05
Trial ID
NCT00369681
Treatments Being Tested